...
首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.
【24h】

Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.

机译:血清素2C受体激动剂和行为饱腹感序列在小鼠中。

获取原文
获取原文并翻译 | 示例

摘要

The studies reported here examined the role of the 5-hydroxytryptamine (5-HT)(2C) receptor subtype in the control of ingestive behaviour in mice. Behavioural satiety sequence (BSS) and food intake measurements were taken, comparing the selective 5-HT(2C) receptor agonist (S)-2-(6-chloro-5-fluoro-indol-l-yl)-l-methylethylamine hydrochloride (Ro 60-0175; 1.0, 3.0 and 10.0 mg/kg) and D-fenfluramine (3.0 mg/kg). Ro 60-0175 produced a dose-dependent decrease in food intake. The effects of Ro 60-0175 (3.0 mg/kg) on the BSS were similar to the hypophagic effects of D-fenfluramine (3.0 mg/kg). In a second experiment, the specific effects on feeding produced by Ro 60-0175 (5.6 mg/kg) were attenuated by pretreatment with the selective 5-HT(2C) receptor antagonist 6-chloro-5-methyl-1-[2(2-methylpyridyl-3-oxy)-pyrid-5-yl carbamoyl] indoline (SB 242084; 0.5 mg/kg). The 5-HT(1B/2C) receptor agonist 1-(m-chlorophenyl)piperazine (mCPP; 3 mg/kg) also produced a substantial decrease in food intake, which was attenuated by SB 242084 (0.5 mg/kg). A dose of the selective 5-HT(1B/1D) antagonist 2'-methyl-4'(5-methyl-[1,2,4]oxadiazol-3-yl)-biphenyl-4-carboxylic acid [4-(5-methoxy-3-(4-methyl-piperazin-1-yl)-phenyl]amide (GR 127935; 3.0 mg/kg) that successfully attenuated the action of the 5-HT(1B) agonist 5-methoxy-3(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole (RU 24969; 5.0 mg/kg) failed to attenuate mCPP-induced hypophagia. These data suggest that Ro 60-0175- and mCPP-induced hypophagia in mice are mediated via activation of 5-HT(2C) receptors and that stimulation of 5-HT(1B) receptors plays only a minor role in mCPP-induced hypophagia.
机译:此处报道的研究检查了5-羟色胺(5-HT)(2C)受体亚型在小鼠吞咽行为控制中的作用。进行了行为饱腹感序列(BSS)和食物摄入量的测量,比较了选择性5-HT(2C)受体激动剂(S)-2-(6-氯-5-氟-吲哚-1-基)-1-甲基乙胺盐酸盐(Ro 60-0175; 1.0、3.0和10.0 mg / kg)和D-芬氟拉明(3.0 mg / kg)。 Ro 60-0175导致食物摄入量呈剂量依赖性下降。 Ro 60-0175(3.0 mg / kg)对BSS的作用与D-芬氟拉明(3.0 mg / kg)的下吞咽作用相似。在第二个实验中,使用选择性5-HT(2C)受体拮抗剂6-氯-5-甲基-1- [2( [2-甲基吡啶基-3-氧]-吡啶-5-基氨基甲酰基]吲哚啉(SB 242084; 0.5 mg / kg)。 5-HT(1B / 2C)受体激动剂1-(间氯苯基)哌嗪(mCPP; 3 mg / kg)也使食物摄入量显着下降,并被SB 242084(0.5 mg / kg)减弱。剂量的选择性5-HT(1B / 1D)拮抗剂2'-甲基-4'(5-甲基-[1,2,4]恶二唑-3-基)-联苯-4-羧酸[4-( 5-甲氧基-3-(4-甲基-哌嗪-1-基)-苯基]酰胺(GR 127935; 3.0 mg / kg)成功减弱了5-HT(1B)激动剂5-甲氧基-3( 1,2,3,6-四氢吡啶-4-基)-1H-吲哚(RU 24969; 5.0 mg / kg)未能减轻mCPP引起的吞咽障碍,这些数据表明Ro 60-0175-和mCPP引起的吞咽障碍。小鼠是通过激活5-HT(2C)受体介导的,并且对5-HT(1B)受体的刺激在mCPP诱导的吞咽不足中仅起较小作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号